{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaginose bactérienne : Questions médicales les plus fréquentes",
"headline": "Vaginose bactérienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaginose bactérienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-21",
"dateModified": "2025-05-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaginose bactérienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaginite",
"url": "https://questionsmedicales.fr/mesh/D014627",
"about": {
"@type": "MedicalCondition",
"name": "Vaginite",
"code": {
"@type": "MedicalCode",
"code": "D014627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.100.250.894.906"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaginose bactérienne",
"alternateName": "Vaginosis, Bacterial",
"code": {
"@type": "MedicalCode",
"code": "D016585",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christina A Muzny",
"url": "https://questionsmedicales.fr/author/Christina%20A%20Muzny",
"affiliation": {
"@type": "Organization",
"name": "Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA."
}
},
{
"@type": "Person",
"name": "Jack D Sobel",
"url": "https://questionsmedicales.fr/author/Jack%20D%20Sobel",
"affiliation": {
"@type": "Organization",
"name": "Division of Infectious DiseasesWayne State University School of Medicine, Detroit, Michigan, USA jsobel@med.wayne.edu rakins@med.wayne.edu."
}
},
{
"@type": "Person",
"name": "Jane R Schwebke",
"url": "https://questionsmedicales.fr/author/Jane%20R%20Schwebke",
"affiliation": {
"@type": "Organization",
"name": "Division of Infectious Diseases, University of Alabama at Birmingham; Birmingham, AL, USA."
}
},
{
"@type": "Person",
"name": "Nuno Cerca",
"url": "https://questionsmedicales.fr/author/Nuno%20Cerca",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, Braga, 4710-057, Portugal."
}
},
{
"@type": "Person",
"name": "David N Fredricks",
"url": "https://questionsmedicales.fr/author/David%20N%20Fredricks",
"affiliation": {
"@type": "Organization",
"name": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems.",
"datePublished": "2023-11-10",
"url": "https://questionsmedicales.fr/article/37950307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13014-023-02370-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "A method for delivering the required neutron fluence in an accelerator-based boron neutron capture therapy system employing a lithium target.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38755333",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-62060-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of MLC positioning deviations using log files and establishment of specific assessment parameters for different accelerators with IMRT and VMAT.",
"datePublished": "2022-07-16",
"url": "https://questionsmedicales.fr/article/35842671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13014-022-02097-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spectrometry of leakage photoneutrons of 18 MV medical accelerator head by Sohrabi passive multi-directional spherical neutron spectrometry system.",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35679769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejmp.2022.04.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases.",
"datePublished": "2023-02-27",
"url": "https://questionsmedicales.fr/article/36847751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1754-9485.13519"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies urogénitales",
"item": "https://questionsmedicales.fr/mesh/D000091642"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies génitales",
"item": "https://questionsmedicales.fr/mesh/D000091662"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de l'appareil génital féminin",
"item": "https://questionsmedicales.fr/mesh/D005831"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladies du vagin",
"item": "https://questionsmedicales.fr/mesh/D014623"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vaginite",
"item": "https://questionsmedicales.fr/mesh/D014627"
},
{
"@type": "ListItem",
"position": 7,
"name": "Vaginose bactérienne",
"item": "https://questionsmedicales.fr/mesh/D016585"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaginose bactérienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaginose bactérienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaginose bactérienne",
"description": "Comment diagnostique-t-on la vaginose bactérienne ?\nQuels tests sont utilisés pour confirmer la vaginose ?\nLes symptômes sont-ils suffisants pour le diagnostic ?\nPeut-on confondre la vaginose avec d'autres infections ?\nQuel rôle joue le pH vaginal dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Particle+Accelerators&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaginose bactérienne",
"description": "Quels sont les symptômes courants de la vaginose ?\nLa vaginose peut-elle être asymptomatique ?\nComment décrire l'odeur associée à la vaginose ?\nLes pertes vaginales sont-elles toujours présentes ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Particle+Accelerators&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaginose bactérienne",
"description": "Comment prévenir la vaginose bactérienne ?\nLes rapports sexuels affectent-ils le risque de vaginose ?\nLes probiotiques peuvent-ils aider à prévenir la vaginose ?\nLe tabagisme influence-t-il le risque de vaginose ?\nLes vêtements peuvent-ils affecter la santé vaginale ?",
"url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Particle+Accelerators&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaginose bactérienne",
"description": "Quels traitements sont disponibles pour la vaginose ?\nLes traitements sont-ils efficaces à 100 % ?\nPeut-on traiter la vaginose avec des remèdes naturels ?\nFaut-il traiter la vaginose si elle est asymptomatique ?\nLes partenaires doivent-ils être traités ?",
"url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Particle+Accelerators&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaginose bactérienne",
"description": "Quelles complications peuvent survenir avec la vaginose ?\nLa vaginose peut-elle affecter la fertilité ?\nY a-t-il un lien entre vaginose et grossesse ?\nLes infections urinaires sont-elles liées à la vaginose ?\nLa vaginose peut-elle causer des douleurs pelviennes ?",
"url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Particle+Accelerators&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaginose bactérienne",
"description": "Quels sont les principaux facteurs de risque de vaginose ?\nL'utilisation de contraceptifs affecte-t-elle le risque ?\nLes antécédents d'infections vaginales augmentent-ils le risque ?\nLe stress peut-il influencer la vaginose ?\nLes changements alimentaires jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Particle+Accelerators&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la vaginose bactérienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et des tests de pH vaginal et de sécrétions."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la vaginose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'examen microscopique et le test de l'amine peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils suffisants pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être corroborés par des tests de laboratoire pour un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Peut-on confondre la vaginose avec d'autres infections ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec des infections comme la candidose ou les IST."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le pH vaginal dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un pH vaginal supérieur à 4,5 est souvent un indicateur de vaginose bactérienne."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la vaginose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des pertes vaginales anormales, une odeur forte et des démangeaisons."
}
},
{
"@type": "Question",
"name": "La vaginose peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines femmes peuvent ne présenter aucun symptôme malgré la présence de l'infection."
}
},
{
"@type": "Question",
"name": "Comment décrire l'odeur associée à la vaginose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'odeur est souvent décrite comme un parfum de poisson, surtout après les rapports sexuels."
}
},
{
"@type": "Question",
"name": "Les pertes vaginales sont-elles toujours présentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines femmes peuvent avoir des pertes minimes ou absentes malgré l'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les femmes."
}
},
{
"@type": "Question",
"name": "Comment prévenir la vaginose bactérienne ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène vaginale et éviter les douches vaginales peut aider à prévenir."
}
},
{
"@type": "Question",
"name": "Les rapports sexuels affectent-ils le risque de vaginose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir de nouveaux partenaires sexuels ou des rapports non protégés peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les probiotiques peuvent-ils aider à prévenir la vaginose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les probiotiques peuvent aider à rétablir l'équilibre vaginal."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de vaginose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de vaginose bactérienne."
}
},
{
"@type": "Question",
"name": "Les vêtements peuvent-ils affecter la santé vaginale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements serrés ou en matières synthétiques peut favoriser la vaginose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vaginose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques comme le métronidazole ou la clindamycine sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à 100 % ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que souvent efficaces, il existe un risque de récidive après le traitement."
}
},
{
"@type": "Question",
"name": "Peut-on traiter la vaginose avec des remèdes naturels ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines femmes essaient des remèdes naturels, mais leur efficacité n'est pas prouvée scientifiquement."
}
},
{
"@type": "Question",
"name": "Faut-il traiter la vaginose si elle est asymptomatique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est recommandé même sans symptômes, surtout avant une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Les partenaires doivent-ils être traités ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, le traitement des partenaires n'est pas nécessaire, sauf en cas de symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la vaginose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent un risque accru d'infections sexuellement transmissibles et de complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "La vaginose peut-elle affecter la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que rare, une vaginose non traitée peut contribuer à des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre vaginose et grossesse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaginose peut augmenter le risque de complications pendant la grossesse, comme l'accouchement prématuré."
}
},
{
"@type": "Question",
"name": "Les infections urinaires sont-elles liées à la vaginose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes atteintes de vaginose peuvent avoir un risque accru d'infections urinaires."
}
},
{
"@type": "Question",
"name": "La vaginose peut-elle causer des douleurs pelviennes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que rare, certaines femmes peuvent ressentir des douleurs pelviennes en raison de la vaginose."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de vaginose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des changements hormonaux, des rapports sexuels fréquents et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'utilisation de contraceptifs affecte-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains contraceptifs hormonaux peuvent influencer le déséquilibre bactérien vaginal."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections vaginales augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes ayant des antécédents d'infections vaginales sont plus susceptibles de développer une vaginose."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer la vaginose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter le système immunitaire et augmenter le risque d'infections vaginales."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affecter la flore vaginale et augmenter le risque de vaginose."
}
}
]
}
]
}
Few dosimetric comparisons have been published between linear accelerator (LA)-based systems and CyberKnife (CK)-based robotic radiosurgery systems for cardiac radio-ablation in ventricular tachycardi...
Thirteen patients who underwent noninvasive cardiac radio-ablation by LA were included. The prescribed dose was 25 Gy in 1 fraction, and the average planning target volume was 49.8 ± 31.0 cm...
Both the CK and LA plans accomplished appropriate dose coverage and normal tissue sparing. Compared with the LA plans, the CK plans achieved significantly lower gradient indices (3.12 ± 0.71 vs. 3.48 ...
Both CK and LA are ideal modalities for noninvasive cardiac radio-ablation. Upfront treatment should be considered based on clinical intent....
Accelerator-based boron neutron capture therapy (BNCT) systems employing a solid-state lithium target indicated the reduction of neutron flux over the lifetime of a target, and its reduction could rep...
The study evaluated the differences in leaf positioning deviations by the log files of three advanced accelerators with two delivery techniques, and established specific assessment parameters of leaf ...
A total of 420 treatment plans with 5 consecutive treatment log files were collected from the Trilogy, TrueBeam and Halcyon accelerators. Millennium MLC was equipped on the Trilogy and TrueBeam accele...
The average maximum leaf RMS errors of the Trilogy in the IMRT and VMAT plans were 0.44 ± 0.09 mm and 0.79 ± 0.07 mm, respectively, which were higher than the TrueBeam's 0.03 ± 0.01 mm, 0.03 ± 0.01 mm...
Compared with the quality assurance guidelines, the MLC positioning deviations tolerances of the three accelerators should be tightened. For both IMRT and VMAT techniques, the 95th percentile error an...
Spectrometry of leakage photoneutrons (PN) of a Siemens ONCOR medical linear accelerator head by applying recently invented Sohrabi passive multi-directional multi-detector neutron spherical spectrome...
The neutron spectrometry system applied consists of 6 polycarbonate/...
The well-resolved unfolded directional leakage PN spectra obtained at the 3 positions showed a thermal PN peak of lower intensityfollowed by a tail of epithermal PNs before reaching a fast PN higher p...
Due to importance of leakage PN spectra of an accelerator head being of scientific interest and for meeting regulatory and safety standards, well-resolved leakage PN spectra of 3 locations of the medi...
Balancing disease control and treatment-related toxicities can be challenging when treating higher-risk brain metastases (BMs) that are larger in size or eloquent anatomical locations. Hypofractionate...
We retrospectively analysed 185 consecutive individual lesions from 152 patients with intact BMs treated with hfSRS between 1 July 2016 and 31 October 2019 and followed up to 30 April 2022 with serial...
The median follow-up was 38.0 months, and the median survival post-SRS was 9.5 months. The cumulative incidence rate of RN was 13.2% (95% CI: 7.0-24.7%), and 18.1% of patients with confirmed RN were s...
Our results support the predicted radiobiological benefit of the use of hfSRS in high-risk BMs to limit treatment-related toxicity with low risk for symptomatic RN comparable with lower risk populatio...
Laser plasma-based particle accelerators attract great interest in fields where conventional accelerators reach limits based on size, cost or beam parameters. Despite the fact that particle in cell si...
Our objective was to provide a method for selecting reference beam model and evaluating the dosimetric accuracy of volumetric modulated arc therapy (VMAT) plans delivered on three Elekta beam-matched ...
Applications of electron accelerators range from nuclear waste package assay and security-related tasks to radiation therapy. Studies aiming at characterizing photoneutron fluxes generated by electron...
The present study is aimed at exploring different scanning parameters, detectors and their orientations for time-efficient and accurate commissioning of a 6 MV clinical linear accelerator (LINAC). Bea...
This study aims to develop and validate a simple geometric model of the accelerator head, from which a particle phase space can be calculated for application to fast Monte Carlo dose calculation in re...
A dual-source model of the head of a Versa HD accelerator (Elekta AB, Stockholm, Sweden) was created. The model used parameters chosen to be compatible with those of 6-MV flattened and 6-MV flattening...
For simple square fields in a water phantom, the calculated dose distribution agrees to within ±2% with that from the commercial treatment planning system, except in the buildup region, where the DPM ...
The phase space model presented allows convenient calculation of a phase space for application to Monte Carlo dose calculation, with straightforward translation of beam parameters from the RayStation ...